Close Menu

NEW YORK – Quest Diagnostics reported on Wednesday that revenues for its first quarter were down 4 percent year over year.

For the three months ended March 31, total revenues fell to $1.82 billion from $1.89 but beat the analysts' average estimate of $1.75 billion. Revenues from the company's Diagnostic Information Services fell $1.74 billion from $1.81 billion.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.


As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Sponsored by

This webinar will present a case study from in vitro diagnostics developer SpeeDx on its experience building a complete sample-to-result workflow — encompassing instrumentation and data analysis software — for its qPCR-based ResistancePlus MG Mycoplasma genitalium assay.